NH Nongwoobio Co., Ltd. (KOSDAQ:054050)
8,430.00
0.00 (0.00%)
At close: Feb 19, 2026
NH Nongwoobio Revenue
NH Nongwoobio had revenue of 38.88B KRW in the quarter ending September 30, 2025, a decrease of -1.08%. This brings the company's revenue in the last twelve months to 151.03B, up 5.23% year-over-year. In the year 2024, NH Nongwoobio had annual revenue of 144.68B with 6.50% growth.
Revenue (ttm)
151.03B
Revenue Growth
+5.23%
P/S Ratio
0.90
Revenue / Employee
453.56M
Employees
333
Market Cap
135.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 144.68B | 8.84B | 6.50% |
| Dec 31, 2023 | 135.84B | 2.44B | 1.83% |
| Dec 31, 2022 | 133.40B | 557.04M | 0.42% |
| Dec 31, 2021 | 132.84B | 2.81B | 2.16% |
| Dec 31, 2020 | 130.03B | 8.76B | 7.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kortek | 363.35B |
| HYUNDAI BIOLAND | 129.68B |
| Meta Biomed | 99.77B |
| Com2uS Holdings | 91.57B |
| Samik Pharmaceutical Company LTD. | 58.88B |
| SEC Co.,Ltd. | 56.35B |
| ALT Co., Ltd | 43.21B |
| YAS Co., Ltd. | 28.24B |